How to get out with ku70 colon cancer?(Jan 2024)

Ku70 is a protein involved in DNA repair and has been found to play a role in colon homeostasis, separate from its nonhomologous end joining (NHEJ) function. In Ku70-deficient mice, postmortem analysis revealed abnormal colon enlargement in 80% of the Ku70-deficient mice, which was not observed in Lig4-deficient mice or Ku70+/−p53R172P littermates. 

The absence of Ku70 led to DNA damage accumulation in colonic epithelial cells, chronic inflammation with infiltrating CD4+ T cells and other innate immune cells, and increased IL-6- and TNF-α-producing cells. Most of the Ku70-deficient mice developed different degrees of colonic abnormalities, including loss of goblet cells, hyperplasia, dysplasia, and adenoma, with some progressing to invasive colorectal cancer (CRC).In another study, researchers found that Ku70 acetylation mediated TSA-induced apoptosis in CRC cells, and Ku70 was found to be indispensable in TSA-induced apoptosis due to its role in protecting Bax from proteosomal degradation. This suggests that targeting Ku70 could potentially be a therapeutic approach for CRC.

ku70 and how is it related to colon cancer

Ku70 is a protein involved in DNA repair and has been found to play a role in colon homeostasis, separate from its nonhomologous end joining (NHEJ) function. In Ku70-deficient mice, postmortem analysis revealed abnormal colon enlargement in 80% of the Ku70-deficient mice, which was not observed in Lig4-deficient mice or Ku70+/−p53R172P littermates. The absence of Ku70 led to DNA damage accumulation in colonic epithelial cells, chronic inflammation with infiltrating CD4+ T cells and other innate immune cells, and increased IL-6- and TNF-α-producing cells. Most of the Ku70-deficient mice developed different degrees of colonic abnormalities, including loss of goblet cells, hyperplasia, dysplasia, and adenoma, with some progressing to invasive colorectal cancer (CRC).In Ku70-deficient mice, Ku70 repairs spontaneous DNA damage in the epithelial cells, which prevents the impairment of barrier function caused by the accumulation of DNA damage. Ku70 is also important for building intact adaptive immunity and has a novel role in limiting cell proliferation in the presence of DNA damage, which may result in abnormal cell proliferation.In human colorectal tumors, cytoplasmic Ku70/80 DNA binding activity was only found in three colorectal cancers, whereas adenomas did not show cytoplasmic activity. Ku70/80 DNA binding activity was increased in approximately 50% of adenoma and carcinoma samples, as compared to matched normal tissues. In tumors with increased DNA-binding activity, Ku70 and Ku86 protein expression correlated with the heterodimer binding activity.

how ku70 related to immune system 

Ku70 is related to the immune system in several ways:

1. Cytosolic DNA sensing: Ku70 has been shown to serve as a pattern recognition receptor (PRR) that recognizes cytosolic DNA, playing a role in innate immunity.
2. Immune deficiency: Ku70-deficient mice have a severe combined immune deficiency associated with severely impaired V(D)J recombination.
3. DNA repair and immune response: Ku70 is involved in DNA repair and has been found to play a role in colon homeostasis, separate from its nonhomologous end joining (NHEJ) function. In Ku70-deficient mice, DNA damage accumulation in colonic epithelial cells led to chronic inflammation with infiltrating CD4+ T cells and other innate immune cells, and increased IL-6- and TNF-α-producing cells.
4. Immune biomarker: Ku70 has been found to be a good immune biomarker, meaning it helps predict who will fare better or worse after being diagnosed with bowel cancer. Future bowel cancer screening methods could include checking the levels of Ku70 in abnormal growths of tissue found in the colon, before healthy cells turn cancerous.

how is ku70 expression related to colorectal cancer prognosis

Ku70 expression is related to colorectal cancer prognosis in several ways:

1. Elevated Ku70 expression: In a study of 101 consecutive cases of advanced colorectal carcinoma, the percentage of cells expressing Ku70 in different tumors ranged from 4.2-99.7%, with 52% of cases showing elevated Ku70 expression. Elevated Ku70 expression was found to be a significant variable for prognosis of survival in the study.
2. Downregulated Ku70 expression: Loss of Ku70 expression has been associated with a poor prognosis in colorectal cancer
   
   
   . In a study of 20 patients with colon adenoma and 15 patients with colorectal carcinoma, Ku70/80 DNA binding activity was increased in approximately 50% of adenoma and carcinoma samples compared to matched normal tissues. In tumors with increased DNA-binding activity, Ku70 and Ku86 protein expression correlated with the heterodimer binding activity.
3. Ku70/ATM coexpression: Downregulation of Ku70 and ATM coexpression has been observed in cancer tissues compared to pericancerous tissues. The coexpression pattern of downregulation of Ku70 and ATM was confirmed further in the CRC samples.
4. Ku70 as an immune biomarker: Ku70 is a good immune biomarker, which helps predict who will fare better or worse after being diagnosed with bowel cancer. Future bowel cancer screening methods could include checking the levels of Ku70 in abnormal growths of tissue found in the colon, before healthy cells turn cancerous.

ku70 deficiency affect the immune system

Ku70 deficiency affects the immune system by influencing the innate immune response and contributing to severe combined immune deficiency (SCID). Research has identified Ku70 as a cytosolic DNA sensor that mediates the innate immune response, serving as a pattern recognition receptor (PRR) that recognizes cytosolic DNA. Ku70-deficient animals exhibit a severe combined immune deficiency associated with severely impaired V(D)J recombination, which is essential for the development of functional B and T cells. 

Next steps in research on ku70 and cancer

The next steps in research on Ku70 and cancer include further investigation of its role in innate immunity and DNA repair, as well as the development of new drugs that can "turn on" Ku70 to help fight bowel cancer. Future research may reveal a more comprehensive understanding of the multiple roles of Ku70, especially in the field of Ku70-involved innate immune networks. 

Additionally, future bowel cancer screening methods could include checking the levels of Ku70 in pre-cancerous polyps, abnormal growths of tissue found in the colon, before healthy cells turn cancerous. Overall, further research on Ku70 and its potential therapeutic applications could lead to improved cancer treatments and screening methods.

Conclusion 

Delineation of the molecular mechanisms of Ku70-mediated innate immune response provides novel strategies to regulate innate immune cascades in response to the invasion of foreign pathogens. Therefore, Ku70 deficiency can lead to impaired innate immune responses and compromised adaptive immunity, ultimately affecting the overall immune function of the organism.